News
Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...
US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
A bold move by US President Donald Trump to slash the cost of prescription drugs in America has sent shockwaves through the ...
PhRMA, which gave $1 million to Trump's inaugural fund, warned against parts of Trump's drug pricing executive order.
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
The same official said the administration doesn't "anticipate a negative impact on innovation ... such as Eli Lilly's ...
Announcement pressures pharma stocks on worries profits will be hit if they have to cut prices in US. Read more at ...
Global pharmaceutical stocks took a hit on Monday after U.S. President Donald Trump pledged to slash prescription prices by ...
Trump’s drug pricing order sparks global pharma sell-off as industry warns of stifled innovation and revenue loss in key US ...
Business leaders from major Hoosier companies say they are trying to navigate the uncertain trade environment created by ...
Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
President Trump recently warned big drugmakers that a pharmaceutical "tariff wall" is coming. Investors often view ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results